The Filing Desk

Vital Farms

VITL · Nasdaq · Consumer Staples · Financials, fiscal 2018 to 2025

VITL · Last close · November 13, 2026
$9.07
Value Vital Farms yourself

Vital Farms' revenue rose 25.3% to $759 million in fiscal 2025. Its operating margin was 11.6%, up from 10.5% a year earlier. Free cash flow was −$48 million, against $36 million a year earlier. The diluted share count rose 2.0%.

Vital Farms, Inc. Latest fiscal year ended December 28, 2025 10-K filed February 26, 2026 · 0001193125-26-073423 Updated
Revenue
$759M
25.3%
Operating margin
11.6%
1.2 pts
Net income
$66M
24.1%
Free cash flow
−$48M
$36M a year earlier
Return on equity
21.4%
1.8 pts
Market cap
$389M
Nov 13 close
P/E
—
Loss: no P/E

Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on equity is net income as a share of shareholders' equity. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.

Charts show fiscal years, from the 10-K filings.

What Vital Farms does

Vital Farms sells eggs and butter. Its eggs come from hens on small farms that it says meet its animal welfare standards, and it sells them under its own brand. It was founded in 2007 on a small plot of land in Austin, Texas, with its first sales at farmers markets and restaurants, and Whole Foods Market began carrying its eggs less than a year later.

The company does not run most of the farms itself. It works with a network of more than 600 small farms and does much of the processing, such as washing and packing, in its own facilities, including its Egg Central Station facility in Missouri. Shell eggs make up the vast majority of its net revenue.

Vital Farms is a Delaware public benefit corporation and a Certified B Corporation. It calls its workers crew members.

Its biggest risks, as it describes them

  • Shell eggs make up the vast majority of its revenue, so lower egg sales would hurt it.
  • Much of its egg processing happens at one facility in Missouri, where damage could cause disruption.
  • Needing to expand its processing and production capacity as it grows.
  • Possible trouble keeping or growing its profitability.
  • Needing more financing, and loan terms that limit what it can do.
From Vital Farms's annual report on Form 10-K, filed February 26, 2026, in our words; the 10-K has the full description and every risk factor. Updated with each new annual report.

Income statement

Revenue and net income
US$ billions, fiscal years; net losses in red. Revenue on the left axis, net income on the right; zero is the same line on both.
Revenue (left axis)Net income (right axis)
Gross profit, R&D and operating income
US$ billions, fiscal years. Gross profit is revenue minus the cost of what was sold; research and development is one of the costs paid from it; what remains after all operating costs is operating income. Losses in red.
Gross profitResearch and developmentOperating income
Margins
Percent of revenue
GrossOperatingNetFree cash flow

From fiscal 2018 to 2025, earnings per share grew 36.9% a year and net income 41.6% a year, as new shares raised the share count by 30% and diluted each share's earnings.

Diluted earnings per share
US$ per share, fiscal years, restated for any stock splits; loss years in red.

Returns on capital

Return on capital and on equity
Percent. Return on capital is after-tax operating income over the money invested in the business (debt plus equity, minus cash); return on equity is net income over shareholders' equity. Both use the average of opening and closing balances.
Return on capitalReturn on equity

Balance sheet

Cash and debt
US$ billions, at each fiscal year end. Debt includes finance leases.
Cash and short-term investmentsDebt
Assets, liabilities and equity
US$ billions, at each fiscal year end. Assets equal liabilities plus equity; negative equity in red.
Total assetsTotal liabilitiesShareholders' equity
Debt and liquidity ratios
Times. Debt to equity, current assets over current liabilities, and net debt over EBITDA (a full year's).
Debt to equityCurrent ratioNet debt to EBITDA

Five years at a glance

Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments31138415149
Debt incl. finance leases—————
Net debt (negative means net cash)—————
Net debt to EBITDA—————
Debt to equity—————
Interest coverage1.0x18.5x42.5x62.9x101.1x
Current ratio3.7x3.1x3.0x3.1x2.2x
Quick ratio3.4x2.6x2.5x2.8x1.6x
US$ millions unless stated, at each fiscal year end. Net debt to EBITDA is debt minus cash, divided by operating income before depreciation and amortization: roughly how many years of those earnings the net debt equals. Debt to equity is debt as a multiple of shareholders' equity. Interest coverage is operating income divided by interest expense. The current ratio is current assets over current liabilities; the quick ratio leaves out inventory.

Cash flow

Cash from operations, capital spending and free cash flow
US$ billions, fiscal years. Free cash flow is cash from operations minus capital spending; negative years in red.
Cash from operationsCapital spendingFree cash flow
Stock-based compensation and buybacks
US$ billions, fiscal years. Shares paid to employees (stock-based compensation, a cost that uses no cash) against cash spent buying shares back. Buybacks that only match it leave the share count roughly where it was.
Stock-based compensationShare buybacks
Dividends and buybacks
US$ billions, cash paid in each fiscal year
DividendsShare buybacks
Diluted share count
Weighted-average diluted shares, millions

Projections

Project Vital Farms' revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.

Insider trades

Over the 12 months between November 14, 2025 and November 13, 2026, 12 insiders bought $612,568 of Vital Farms shares on the open market, and 2 insiders sold $4.2 million, all of it under trading plans set up in advance.

Buys and sells by month
US$ millions, open-market purchases (up) and sales (down) by officers, directors and 10% owners in each month.
BoughtSold
DateInsiderTradeSharesPriceValueFiling
Nov 11, 2026Matthew Ohayer10% ownerSold plan23,250$9.56$222,270Form 4
Nov 9, 2026Matthew Ohayer10% ownerSold plan66,200$9.68$640,816Form 4
Nov 6, 2026Matthew Ohayer10% ownerSold plan3,550$9.53$33,832Form 4
May 19, 2026Hoven Reena Chauhan VanChief People OfficerBought2,242$8.92$19,999Form 4
May 18, 2026Glenda J FlanaganDirectorBought6,100$8.33$50,813Form 4
May 15, 2026Stephanie CoonChief Strategy OfficerBought5,895$8.42$49,636Form 4
May 15, 2026Kofi Owusu Amoo-GottfriedDirectorBought2,375$8.45$20,069Form 4
May 14, 2026Joseph Michael HollandChief Supply Chain OfficerBought12,484$8.00$99,872Form 4
May 14, 2026William B. CyrDirectorBought6,000$8.52$51,120Form 4
May 14, 2026Peter Nicholas PappasCSO and President, EggsBought3,500$8.51$29,785Form 4
May 14, 2026Kelly J. KennedyDirectorBought2,500$8.40$21,000Form 4
May 14, 2026Kathryn McKeonCMO and GM, ButterBought604$8.28$5,001Form 4
The latest 12 of 22 trades. Open-market purchases and sales by officers, directors and 10% owners, from their Form 4 filings with the SEC: one row per person, day and filing, at the day's average price. Grants, option exercises and shares withheld for tax aren't counted. Insiders buy and sell for many reasons, such as taxes, spreading their savings or a plan set up months earlier, so a trade on its own says little about where a company is heading. For information only, not investment advice. Insider trades at all companies

Indicators

Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.

IndicatorFY23FY24FY25
Piotroski F-score———
Rule of 4038.7%34.5%18.9%
Altman Z''6.728.146.07
Accruals ratio−10.3%−3.6%7.4%
Piotroski F-score: how many of nine simple tests of profitability, funding and efficiency the company passed in the year (Piotroski, 2000); 8 or 9 is strong, 0 to 2 weak. Rule of 40: revenue growth plus free cash flow margin; software investors treat 40% or more as the bar. Altman Z'': working capital, retained earnings, operating income and equity weighed against assets and liabilities (Altman, 1995); Altman puts above 2.6 in the safe zone and below 1.1 in the distress zone. Accruals ratio: net income minus cash from operations, over average total assets; lower means profit is backed by cash.

The nine F-score tests

TestFY23FY24FY25
Net income is positivePassPassPass
Cash from operations is positivePassPassPass
Return on assets rosePassPassFail
Cash from operations exceeds net incomePassPassFail
Debt fell relative to assets———
Current ratio roseFailPassFail
Share count didn't risePassFailFail
Gross margin rosePassPassFail
Revenue rose relative to assetsPassPassFail
F-score———
Companies that report no gross profit are scored on the other eight.

Compare

Put Vital Farms side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.

Similar companies

CompanyYearRevenue growthOperating marginFree cash flow marginReturn on capitalNet debt to EBITDAF-scoreCompare
Vital FarmsFY2525.3%11.6%−6.3%———
Tootsie Roll IndustriesFY251.3%13.8%13.2%———Compare
FreshpetFY2513.0%6.9%1.1%5.9%0.9x8Compare
John B. Sanfilippo & SonFY266.2%7.6%3.0%16.6%0.4x3Compare
Westrock CoffeeFY2539.8%−3.8%−9.1%−7.2%46.0x3Compare
Each company's latest fiscal year. Fiscal years end in different months, so the periods don't line up exactly. Free cash flow margin is free cash flow as a share of revenue. Net debt to EBITDA is explained under the balance sheet, and the F-score under Indicators.

8 years of figures

Fiscal yearFY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue107141214261362472606759
Revenue growth—31.9%52.3%21.8%38.8%30.3%28.5%25.3%
Gross profit35437483109162230286
Research and development————————
Operating income731202336488
Net income62921265366
Diluted EPS (US$)0.160.070.270.060.030.591.181.44
Diluted shares (millions)3536334344434546
Cash flow
Cash from operations11−51218−8516534
Capital expenditure25101710122982
Free cash flow9−1011−193936−48
Dividends paid00000000
Share buybacks014000000
Acquisitions00000000
Stock-based compensation1124671012
Balance sheet at fiscal year end
Cash and short-term investments—13031138415149
Debt incl. finance leases—51—————
Total assets—62171190215275359519
Total liabilities—302938568290168
Shareholders' equity49142152158193269351
Margins and ratios
Gross margin32.6%30.5%34.8%31.8%30.2%34.4%37.9%37.6%
Operating margin6.3%2.4%5.7%0.0%0.6%7.0%10.5%11.6%
Net margin5.4%1.7%4.1%0.9%0.3%5.4%8.8%8.7%
Free cash flow margin8.9%−7.2%0.6%0.4%−5.1%8.3%6.0%−6.3%
Rule of 40 (growth + FCF margin)—24.7%52.8%22.1%33.6%38.7%34.5%18.9%
Return on capital——14.8%—————
Return on equity——11.7%1.6%0.8%14.6%23.1%21.4%
Return on assets——7.5%1.3%0.6%10.4%16.8%15.1%
Net debt to EBITDA—0.7x−1.9x—————
US$ millions unless stated. Where a later 10-K restated a year, the latest filed figure is shown. Download all figures (CSV, US$ millions)
Source: Vital Farms' Form 10-K filings, from SEC EDGAR. For information only, not investment advice. The Filing Desk is not affiliated with Vital Farms.